Back to Search
Start Over
VolitionRx, Gyros Protein receive an aggregate $1 mn+ Eurostars cash grant to collaborate on developing lung cancer bloo
- Source :
- PharmaBiz. December 7, 2019
- Publication Year :
- 2019
-
Abstract
- VolitionRx Limited, a multi-national life sciences company, announced that it was awarded $820,000 (740,000 Euros) and Gyros Protein Technologies AB, now part of Mesa Laboratories Inc. was awarded $230,000 (206,000 [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.607791633